CBG: The Mother Cannabinoid for Focus and Clean Energy

CBG: The Mother Cannabinoid for Focus and Clean Energy

What is CBG? The "mother cannabinoid" is the 2026 breakout for focus, lower inflammation, and clean pre-workout energy. Here is the science athletes should know.

June 12, 2026

By the OFFFIELD Editorial Team. Published June 12, 2026. Last updated June 23, 2026.

The short answer: CBG (cannabigerol) is the "mother cannabinoid," the compound the cannabis plant builds first and then converts into CBD, THC, and the rest. It is non-intoxicating, and in preclinical research it is studied for anti-inflammatory activity and a focus-leaning, alert profile, which is why many active people now use it for clean daytime energy. This guide is the hub of our Cannabinoids 101 series: it explains what CBG is, what the newest studies actually show, and where it fits in a pre-workout stack.

Key Takeaways

  • CBG is the "mother cannabinoid." The plant produces CBGA first, then enzymes convert it into the precursors of THC, CBD, and others, so CBG is the source compound.
  • It is non-intoxicating. CBG will not get you high, which is part of why many people use it during the day rather than at night.
  • The research is promising but early. A 2025 review described antioxidant and anti-inflammatory activity in preclinical models; most CBG evidence today is laboratory and animal work, not large human trials.
  • Focus is the athlete story. CBG's receptor profile is associated with alertness rather than sedation, which is why it is designed to support clean, jitter-free energy alongside natural caffeine.
  • CBG anchors the OFFFIELD stack. High Performance Energy Gummies pair 10mg CBG with a low dose of THC, while the THC-free Enhanced Energy Gummies build the same idea around 8mg CBG.

Everyone has met CBD by now. It is on the gas station counter, in the seltzer, folded into the post-yoga conversation. But the cannabinoid that quietly makes CBD possible has spent most of that time backstage. That cannabinoid is CBG, and in 2026 it is finally stepping into the light.

CBG, short for cannabigerol, is having its breakout year. Search interest in "what is CBG" keeps climbing, supplement brands are scrambling to add it, and athletes who already understand CBD are asking a sharper question: if CBD calms, what gives me clean focus without the wired edge of another espresso? The answer keeps pointing back to the molecule the cannabis plant builds first.

What is CBG and what does it do?

Here is the part that surprises people. Every cannabinoid in the plant starts as one thing. The cannabis plant produces CBGA, the acidic form of CBG, and enzymes then convert it into the precursors of THC, CBD, and the rest. CBG is the source. That is why researchers and growers call it the mother cannabinoid, or the "mother of all cannabinoids."

Because the plant converts most of its CBGA into other compounds as it matures, mature flower usually contains less than one percent CBG. It is rare, it is expensive to isolate, and for years that scarcity kept it out of the conversation. Extraction and breeding have caught up, and now CBG can stand on its own.

In the body, CBG interacts with the endocannabinoid system (ECS), the network of receptors that helps regulate inflammation, mood, appetite, and recovery. Unlike CBD, which mostly works indirectly, preclinical work shows CBG binding more directly to the CB1 and CB2 receptors and also engaging alpha-2 adrenergic receptors, the same family involved in focus and alertness. That receptor profile is part of why CBG is associated with a sharper, more awake feeling rather than a sedating one.

Is CBG psychoactive?

No. CBG is non-intoxicating. It will not get you high the way THC can. That is one of the main reasons many people use it during the day, when the goal is to stay clear-headed rather than altered. What makes CBG interesting is not a buzz, it is how it works in the body, which is different enough from CBD to matter.

What does the research on CBG actually show?

The inflammation story is the most developed. A 2025 review in Frontiers in Pharmacology catalogued cannabigerol's antioxidant and anti-inflammatory activity across the cardiovascular system, describing its ability to dampen inflammatory signaling in preclinical models. Broader reviews of the cannabinoid describe consistent suppression of inflammatory cytokines in laboratory settings, the same chemical messengers that flare after a hard training block.

The honest caveat: most CBG research today is preclinical, meaning laboratory and animal studies rather than large human trials. The signal is promising and consistent, but the field is young. Anyone selling CBG as a cure is getting ahead of the evidence. What the data describes right now is a credible mechanism studied for lower inflammation and improved focus, which is exactly the profile many athletes look for in a daytime cannabinoid. Treat it as promising support, not a guarantee.

Why is focus the part athletes care about?

Caffeine works. It also overshoots. The jitter, the 3 p.m. crash, the second cup that turns a good warmup into a racing heart at the start line. Most active people are not looking for more stimulation. They are looking for cleaner stimulation, the kind that sharpens attention without hijacking it.

This is where CBG earns its place. Stacked with a moderate dose of natural caffeine, CBG is designed to smooth the experience, supporting alertness while the ECS engagement keeps the edge off. It is less "floor it" and more "find the right gear." For a lifter dialing in a heavy set, a runner settling into tempo pace, or anyone who just needs to be present for a hard hour, that distinction is everything.

It also fits the larger truth OFFFIELD keeps coming back to. The Runner's High is not an endorphin myth, it is an endocannabinoid event. Your best sessions are already an ECS phenomenon. Supporting that system with the right exogenous cannabinoids is not a hack, it is working with the body's own chemistry instead of against it.

How does CBG fit in the OFFFIELD stack?

This is why CBG is not a footnote in our formulas, it is a load-bearing ingredient. Our High Performance Energy Gummies pair 10mg of CBG with CBD, a low dose of THC, and natural caffeine from yerba mate. The CBG and caffeine are designed to support focus and drive, the CBD supports recovery, and the low-dose THC adds the enjoyment that makes you actually want to lace up again.

Prefer to skip THC entirely? The Enhanced Energy Gummies are THC-free and build the same idea around 8mg of CBG with CBD and natural caffeine. Same philosophy, different dial setting. Either way, CBG is doing quiet, unglamorous work in the background, which is fitting for the molecule that builds everything else. You can dig into the full formulation logic on our Science page.

CBG vs CBD: are they rivals?

It is tempting to frame CBG as the new thing replacing CBD. That misses the point. They are teammates. CBD is the broad, calming, recovery-leaning cannabinoid. CBG is the focused, alert, inflammation-targeting one. Together they cover more of the day than either does alone, which is why thoughtful formulas use both rather than picking a side.

The mother cannabinoid spent years building the rest of the family and getting none of the credit. In 2026 it is finally getting its due, not because of hype, but because the way it works lines up neatly with what active people actually want: focus that does not fray, and recovery that keeps showing up.

OFFFIELD's take

We built our energy gummies around CBG because it does exactly what active people ask for: clean, present focus without the wired edge. In a 2026 survey of OFFFIELD subscribers, 96% said they use it every session, 82% train five or more days a week, and 67% are training for a specific race or event. These are people building a daily routine around focus, not chasing a high. (Survey of OFFFIELD subscribers, 2026. Methodology available on request.)

Frequently Asked Questions

What is CBG?
CBG, or cannabigerol, is a non-intoxicating cannabinoid known as the "mother cannabinoid" because the plant produces it first and then converts it into CBD, THC, and others. In preclinical research it is studied for focus-supporting and anti-inflammatory properties.

Does CBG get you high?
No. CBG is non-intoxicating. It will not produce the high associated with THC, which is why many people use it during the day.

What is the difference between CBG and CBD?
CBD tends to be calming and recovery-oriented and works mostly indirectly on the endocannabinoid system. In preclinical work CBG binds more directly to cannabinoid receptors and engages focus-related pathways, so it is often associated with alertness rather than sedation.

Is CBG good for working out?
Early research describes anti-inflammatory and focus-supporting properties, which is why many people use CBG in pre-workout formulas alongside caffeine. Most studies are still preclinical, so treat it as a promising support, not a miracle.

CBG is finally getting its due

The mother cannabinoid spent years building the rest of the cannabinoid family and getting none of the credit. What makes it worth a look now is not hype, it is a receptor profile that lines up with what active people actually need from a daytime cannabinoid: clean focus and steady recovery, studied carefully and stated honestly.

That is what Movement Made Happy has always meant. Train with focus, recover faster, and enjoy every session. Explore the High Performance Energy Gummies for low-dose THC plus 10mg CBG, or the THC-free Enhanced Energy Gummies with 8mg CBG, and dig into the mechanism on our Science page.

Related Reading

This post is the pillar of our Cannabinoids 101 (THC / CBD / CBG / CBN) cluster. Use it as your hub, then go deeper with the related guides:

Sources / References

  1. Krzyżewska A, Kloza M, Kozłowska H. Comprehensive mini-review: therapeutic potential of cannabigerol, focus on the cardiovascular system. Frontiers in Pharmacology. 2025. Journal
  2. Li S, Li W, Malhi NK, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules. 2024. PMC
  3. Nachnani R, Raup-Konsavage WM, Vrana KE. The Pharmacological Case for Cannabigerol (CBG). Journal of Pharmacology and Experimental Therapeutics. 2021. PMC
  4. Fuss J, Steinle J, Bindila L, et al. A runner's high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences (PNAS). 2015. PNAS

Legal disclaimer: OFFFIELD products are hemp-derived and contain federally compliant levels of THC. This article is for informational and educational purposes only and is not medical advice. OFFFIELD products are not intended to diagnose, treat, cure, or prevent any disease. CBG research is largely preclinical and ongoing. Cannabinoids may cause impairment; do not drive or operate machinery after use. Consult a healthcare provider before use, especially if pregnant, nursing, or taking medication. Keep out of reach of children. Must be 21 or older to purchase.

GO BACK